The Studies of the Pathophysiologic Mechanisms of Poor Ulcer Healing & Clinical Improvement to the High Ulcer Rebleeding Rate for Patients With Comorbid Illnesses

Trial Profile

The Studies of the Pathophysiologic Mechanisms of Poor Ulcer Healing & Clinical Improvement to the High Ulcer Rebleeding Rate for Patients With Comorbid Illnesses

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Esomeprazole (Primary) ; Esomeprazole
  • Indications Bleeding ulcer
  • Focus Therapeutic Use
  • Acronyms DDE
  • Most Recent Events

    • 13 Oct 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 29 Sep 2013 Planned number of patients changed from 200 to 300 as reported by ClinicalTrials.gov record.
    • 10 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top